We are thrilled to announce that PERISCOPE, our NextGen AI-driven Software as a Medical Device (SaMD), has been honored with the very prestigious CES 2024 Innovation Award. CES is the world’s premier technology event and the CES Innovation Awards spotlight design and engineering excellence. 

This recognition is proof of our commitment to revolutionizing postoperative care. Harnessing advanced AI/ML technologies, PERISCOPE is set to upgrade surgical care. Our innovative solution predicts the risk of postoperative bacterial infections, aiming to treat earlier, reduce their severity, and alleviate the workload of healthcare staff. This proactive strategy aims to advance precision healthcare, manage escalating costs, and facilitate accurate recovery predictions following surgery.

What sets PERISCOPE apart is our cutting-edge architectural design, enabling a seamless interface with Electronic Health Records and usual HC workflows. Currently, we are actively engaged in the CE certification process, a further proof of our rigorous adherence to the highest quality and safety standards in the European Union.

Leveraging insights from our successful pilot programs in six major hospitals across Europe and the U.S., we have developed a deep understanding of the multifaceted requirements within the healthcare ecosystem. This expertise positions us as a transformative innovator at CES 2024 in Las Vegas, ready to meet the complex demands of healthcare professionals and institutions.

Our participation in CES 2024 is more than just an opportunity to showcase our groundbreaking solution. It’s a platform for us to connect with potential customers, development partners, and investors, further expanding our influence and impact in the global healthcare market. We are particularly excited about the potential for new collaborations with hospitals and other EHR vendors, driving forward our vision of transforming healthcare delivery through innovation.